Announcement

Heading back to our roots. Xterna is part of the inaugural University of Cambridge Founders programme. The Cambridge biotech ecosystem is one of the strongest in the world, no better place to continue developing Xterna.

Press release here:

https://www.linkedin.com/posts/founders-at-the-university-of-cambridge_meet-the-11-start-ups-selected-for-the-first-activity-7173267097580474368-tW0C?utm_source=share&utm_medium=member_desktop

March 2024

Announcement

Grant success! We have received a UKRI, Innovate UK feasibility funding grant to continue Xterna’s groundbreaking research. Read more from the Science Creates press release here: https://www.linkedin.com/posts/sciencecreates_ukri-feasibility-funding-awardees-activity-7183485295906955264-fh4d?utm_source=combined_share_message&utm_medium=member_desktop

February 2024

Announcement

The excitement continues, we are happy to announce our recent acceptance on the Nucleate Activator programme, UK chapter. Since inception in 2020, global Nucleate Activator teams have raised over $190M. Excited to learn more from the fantastic mentors across the globe.

November 2023

Announcement

November 2023

We are excited to announce that we are participating in the Science Creates accelerator programme in Bristol (UK). With this backing from the UKRI, we are excited to begin Xterna’s journey.